NG, KIU YAN CHARLOTTE
 Distribuzione geografica
Continente #
AS - Asia 1.727
NA - Nord America 1.382
SA - Sud America 487
EU - Europa 238
AF - Africa 37
OC - Oceania 5
Totale 3.876
Nazione #
US - Stati Uniti d'America 1.335
SG - Singapore 1.051
BR - Brasile 426
CN - Cina 383
HK - Hong Kong 93
VN - Vietnam 75
IT - Italia 45
GB - Regno Unito 37
DE - Germania 31
BD - Bangladesh 25
AR - Argentina 22
RU - Federazione Russa 22
IN - India 21
CA - Canada 18
ZA - Sudafrica 18
MX - Messico 17
PL - Polonia 16
EC - Ecuador 15
TR - Turchia 14
FI - Finlandia 13
FR - Francia 10
NL - Olanda 10
IE - Irlanda 9
JP - Giappone 9
UZ - Uzbekistan 9
VE - Venezuela 8
SE - Svezia 7
CZ - Repubblica Ceca 6
ES - Italia 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
IQ - Iraq 5
MA - Marocco 5
NG - Nigeria 5
PY - Paraguay 5
UA - Ucraina 5
AU - Australia 4
CR - Costa Rica 4
LB - Libano 4
LV - Lettonia 4
PK - Pakistan 4
AM - Armenia 3
ID - Indonesia 3
KE - Kenya 3
KG - Kirghizistan 3
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
LT - Lituania 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
TH - Thailandia 2
TN - Tunisia 2
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PT - Portogallo 1
SN - Senegal 1
TJ - Tagikistan 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.876
Città #
Singapore 336
The Dalles 284
Shanghai 242
New York 220
Dallas 144
Ashburn 129
Hong Kong 93
Beijing 87
São Paulo 37
Boardman 36
Los Angeles 32
Ho Chi Minh City 31
Wilmington 20
San Mateo 18
Hanoi 17
Johannesburg 16
Milan 16
Brooklyn 15
Munich 15
Warsaw 15
Helsinki 12
Santa Clara 12
Chennai 11
Rio de Janeiro 11
Belo Horizonte 9
Brasília 9
Seattle 9
Tashkent 9
Tokyo 9
Abbiategrasso 8
San Francisco 8
Ankara 7
Boston 7
Council Bluffs 7
Denver 7
Fortaleza 7
London 7
Manchester 7
Atlanta 6
Brno 6
Campinas 6
Chandler 6
Dhaka 6
Dublin 6
Goiânia 6
Guayaquil 6
Lawrence 6
Orem 6
Princeton 6
Fairfield 5
Mexico City 5
Paris 5
Phoenix 5
Porto Alegre 5
Salvador 5
Stockholm 5
Benin City 4
Buenos Aires 4
Chicago 4
Erbil 4
Guarulhos 4
Hangzhou 4
Joinville 4
Maceió 4
Moscow 4
Natal 4
Piracicaba 4
Quito 4
Recife 4
Reston 4
Riga 4
San José 4
Sydney 4
Amsterdam 3
Ann Arbor 3
Araçatuba 3
Betim 3
Birmingham 3
Biên Hòa 3
Bragança Paulista 3
Calgary 3
Cariacica 3
Casablanca 3
Colombo 3
Curitiba 3
Da Nang 3
Florianópolis 3
Haiphong 3
Istanbul 3
Limeira 3
Limerick 3
Manaus 3
Mauá 3
Montreal 3
Nairobi 3
Naples 3
Newark 3
Poplar 3
Ribeirão Preto 3
Riyadh 3
Totale 2.209
Nome #
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 76
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies 51
Molecular classification of hepatocellular carcinoma: The view from metabolic zonation 51
Combining two antibodies to define E-cadherin loss of expression in non-lobular breast carcinomas: when less is more 50
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 46
Metaplastic breast carcinoma: more than a special type 46
The protein histidine phosphatase LHPP is a tumour suppressor 45
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations 44
Breast cancer intratumor genetic heterogeneity: causes and implications 44
Prognostic signatures in breast cancer: correlation does not imply causation 43
The Genomic Landscape of Male Breast Cancers 43
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas 42
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations 42
Breast cancer intra-tumor heterogeneity 41
Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma 40
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes 39
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer 38
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 37
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle 36
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes 35
Alterations in Homologous Recombination Repair Genes in Prostate Cancer Brain Metastases 35
Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening 35
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast 34
ESR1 and endocrine therapy resistance: more than just mutations 34
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support 34
Genomic profiling of histological special types of breast cancer 34
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook 33
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer 33
The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas 33
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations 33
Genomic landscape of adenoid cystic carcinoma of the breast 33
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance 32
Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis 32
Progression from ductal carcinoma in situ to invasive breast cancer: revisited 32
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) 32
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 32
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 32
PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data 32
Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues 32
Genomic characterization of metastatic breast cancers 31
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 31
Patient-derived xenografts and organoids model therapy response in prostate cancer 31
Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer 31
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer 30
Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships 30
Chromosomal instability determines taxane response 30
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma 30
SCIM: universal single-cell matching with unpaired feature sets 30
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing 30
Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights 30
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 29
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast 29
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 29
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes 29
Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer 29
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 29
High-resolution genomic profiling of thyroid lesions uncovers preferential copy number gains affecting mitochondrial biogenesis loci in the oncocytic variants 29
Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors 28
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis 28
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma 28
Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: the role of massively parallel sequencing 28
Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion 28
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens 28
Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases 28
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors 27
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancer 27
Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer 27
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models 27
Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways 27
Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors 27
Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology 27
Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissue 26
Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients 26
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma 26
The Role of Long Non-Coding RNAs in Hepatocarcinogenesis 26
Discovery of heterozygous KRT10 alterations in MAUIE cases underlines the importance of regular skin cancer screening in ichthyosis with confetti 26
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer 26
Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile 26
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function 26
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer 25
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2(+) Breast Cancer 25
NGS-pipe: a flexible, easily extendable and highly configurable framework for NGS analysis 25
SF3B1 mutations constitute a novel therapeutic target in breast cancer 25
Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein 25
Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected] 25
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases 25
Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing 24
PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma 24
Uterine adenosarcomas are mesenchymal neoplasms 24
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples 24
Establishing standardized immune phenotyping of metastatic melanoma by digital pathology 24
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers 24
Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast 24
PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform 24
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses 23
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers 23
Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology 23
Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model 23
Nestin and CD34 expression in colorectal cancer predicts improved overall survival 23
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification 23
Totale 3.151
Categoria #
all - tutte 31.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 4 7 3 13 8 0 11
2021/202229 0 0 0 9 0 0 0 7 0 1 4 8
2022/202339 12 0 6 1 4 1 0 3 4 6 2 0
2023/2024765 1 3 4 2 0 342 54 56 14 9 111 169
2024/20251.469 28 5 7 18 11 168 85 89 317 420 156 165
2025/20261.674 613 340 158 369 125 69 0 0 0 0 0 0
Totale 4.023